GO:0086003 cardiac muscle cell contraction: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0086003 cardiac muscle cell contraction is the actin filament-based process in which cytoplasmic actin filaments slide past one another to shorten a cardiac muscle cell.
• The term is a biological_process in the Gene Ontology and is distinct from skeletal or smooth muscle contraction, although it shares the same fundamental sarcomeric machinery.
• Contraction depends on calcium binding to troponin C, which relieves tropomyosin inhibition and allows myosin heads to cycle on actin.
• Cardiomyocytes are mechanosensitive: contraction and stretch feed back on electrical and chemical signaling through mechano-electric and mechano-chemo-transduction.
• Human induced pluripotent stem cell-derived cardiac muscle models and direct reprogramming approaches now allow contraction to be studied in human cells.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models are central to testing which genes causally regulate cardiac muscle cell contraction.
Description
GO:0086003 cardiac muscle cell contraction is the Gene Ontology biological process that describes the actin filament-based shortening of a cardiac muscle cell, in which cytoplasmic actin filaments slide past one another. This term captures the final mechanical output of the cardiomyocyte and is therefore a central node for researchers working on heart physiology, inherited cardiomyopathy, and regenerative medicine. Because contraction is the defining function of the heart, any gene that alters sarcomere assembly, calcium handling, or mechanosignaling can be mapped back to this process. The term is intentionally narrower than generic muscle contraction: it applies specifically to cardiac muscle cells, which have their own isoform repertoire, regulatory tuning, and disease associations. In practice, researchers use GO:0086003 to annotate genes and proteins whose perturbation changes the contractile behavior of cardiomyocytes, whether in primary cells, human induced pluripotent stem cell-derived cardiomyocytes, or engineered cardiac tissues. Understanding this term also matters for translational work, because contractile dysfunction is a shared endpoint of many cardiac diseases, including cardiomyopathies linked to troponin and sarcomeric gene mutations. As a result, GO:0086003 sits at the intersection of molecular motor biology, calcium signaling, mechanobiology, and cardiac disease modeling.
cardiac muscle cell contraction At A Glance
| GO ID | GO:0086003 |
|---|---|
| GO term | cardiac muscle cell contraction |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Actin filament-based shortening of a cardiac muscle cell |
| Definition source | QuickGO definition: the actin filament-based process in which cytoplasmic actin filaments slide past one another resulting in contraction of a cardiac muscle cell |
| Cellular context | Cytoplasm of cardiac muscle cells, especially the sarcomere |
| Key trigger | Calcium binding to troponin C on the thin filament |
| Related processes | Muscle contraction, calcium signaling, mechanotransduction |
What Is GO:0086003?
In our own words, GO:0086003 cardiac muscle cell contraction is the process by which actin filaments inside a cardiac muscle cell slide relative to one another, driven by the cyclic interaction of myosin with actin, so that the cell shortens and generates force. The QuickGO definition specifies that this is an actin filament-based process occurring in the cytoplasm of a cardiac muscle cell, which distinguishes it from other actin-based motility processes and from contraction in non-cardiac muscle. The process is initiated when calcium binds the thin-filament regulatory complex, relieving inhibition of the actin-myosin interaction, and it is terminated when calcium is removed and the thin filament is re-inhibited. Because the definition is anchored to actin filament sliding, annotations under this term typically involve sarcomeric proteins, calcium-handling proteins, and their regulators.
Why Is cardiac muscle cell contraction Important in Cell Biology?
GO:0086003 cardiac muscle cell contraction is important because it is the process that converts chemical and electrical signals into the mechanical work of the heart, and its failure is a direct cause of heart failure and arrhythmia. Researchers annotate genes to this term when they want to state that a gene product participates in the contractile apparatus or its regulation, which makes the term a hub for interpreting cardiac genomics, drug responses, and disease models. Because contraction is also mechanosensitive, it feeds back on gene expression and electrical activity, so the term connects cell biology to tissue-level physiology.
• Defines the core mechanical output of cardiomyocytes and the heart.
• Provides a controlled vocabulary for annotating sarcomeric and calcium-handling genes.
• Links inherited mutations in troponin and other sarcomeric genes to contractile dysfunction.
• Underpins mechano-electric and mechano-chemo-transduction studies in cardiomyocytes.
• Supports nucleus mechanosensing research, where contraction-derived forces influence transcription.
• Enables human cell models through hiPSC-derived cardiac muscle and direct reprogramming.
• Guides optogenetic and microfluidic assays of single-cell contraction.
• Serves as a benchmark phenotype for CRISPR screens of cardiac genes.
• Connects molecular motor biology to clinical cardiomyopathy phenotypes.
• Provides a measurable endpoint for drug and gene therapy testing in cardiac models.
What Happens During cardiac muscle cell contraction?
Excitation and calcium entry
In simple terms: An electrical signal tells the heart cell to let calcium in, which is the starting gun for contraction.
Cardiac muscle cell contraction begins with membrane depolarization that opens voltage-gated calcium channels, allowing calcium to enter the cytoplasm and trigger further calcium release from intracellular stores. This excitation-contraction coupling step is the point at which electrical activity is converted into a chemical calcium signal. Because the heart must contract rhythmically, this step is tightly coupled to the cardiac action potential and is a target of arrhythmia research.
Calcium binding to troponin and thin-filament activation
In simple terms: Calcium sticks to a switch on the actin filament and moves a blocker out of the way.
When cytoplasmic calcium rises, it binds troponin C on the thin filament, causing a conformational change that moves tropomyosin and exposes myosin-binding sites on actin. This thin-filament activation is the essential regulatory step that permits the actin-myosin interaction to proceed. Mutations in troponin C and related thin-filament proteins alter this calcium-sensitive switch and have been linked to cardiac muscle dysfunction.
Cross-bridge cycling and actin filament sliding
In simple terms: Myosin motors grab actin and pull, making the filaments slide and the cell shorten.
Once actin sites are exposed, myosin heads bind actin, undergo a power stroke, and then detach in an ATP-dependent cycle, causing actin filaments to slide past one another. This cross-bridge cycling is the direct mechanical basis of cardiac muscle cell contraction and is the core of the GO:0086003 definition. The rate and force of cycling are tuned by myosin isoforms, regulatory light chains, and the mechanical load on the cell.
Relaxation and calcium removal
In simple terms: Calcium is pumped away, the switch resets, and the cell relaxes so the heart can refill.
Contraction ends when cytoplasmic calcium is removed by sarcoplasmic reticulum calcium ATPase and other transporters, allowing troponin and tropomyosin to re-inhibit the thin filament. Relaxation is as important as contraction for cardiac function, and defects in calcium removal can impair diastolic filling. This step also resets the sarcomere for the next contraction cycle.
Mechanotransduction feedback
In simple terms: The cell senses its own pull and adjusts its signals and genes in response.
Contraction generates mechanical forces that are sensed by cardiomyocytes and converted into electrical and chemical signals, a process called mechano-electric and mechano-chemo-transduction. Nucleus mechanosensing further links contractile forces to changes in gene expression. This feedback means GO:0086003 is not only an output of signaling but also an input to cardiac cell regulation.
Key Genes Involved in GO:0086003 cardiac muscle cell contraction
The following genes and proteins are central to cardiac muscle cell contraction and are commonly studied with CRISPR models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYH7 | Beta-myosin heavy chain motor protein | Sarcomeric motor for actin sliding; cardiomyopathy gene |
| MYH6 | Alpha-myosin heavy chain motor protein | Atrial and cardiac myosin isoform; contractile tuning |
| ACTC1 | Cardiac actin thin filament | Core actin filament component for sliding |
| TNNT2 | Cardiac troponin T | Thin-filament regulatory switch; disease mutations |
| TNNI3 | Cardiac troponin I | Inhibitory subunit of troponin; calcium regulation |
| TNNC1 | Cardiac troponin C | Calcium-binding switch for contraction |
| TPM1 | Alpha-tropomyosin | Blocks actin sites at rest; regulated by troponin |
| MYL2 | Regulatory myosin light chain | Modulates myosin cycling and force |
| MYL3 | Essential myosin light chain | Structural and regulatory myosin component |
| TTN | Titin | Sarcomere elasticity and passive tension |
| MYBPC3 | Myosin-binding protein C | Modulates cross-bridge cycling |
| ATP2A2 | SERCA2 calcium pump | Calcium removal and relaxation |
| RYR2 | Ryanodine receptor 2 | Sarcoplasmic reticulum calcium release |
| CACNA1C | Voltage-gated calcium channel | Calcium entry for excitation-contraction coupling |
| NPPA | Natriuretic peptide A | Cardiac stress marker linked to contraction |
| GATA4 | Cardiac transcription factor | Regulates cardiac gene programs including contractile genes |
| MEF2C | Cardiac transcription factor | Direct reprogramming factor for cardiomyocytes |
How Is cardiac muscle cell contraction Regulated?
Cardiac muscle cell contraction is regulated at multiple levels. Acutely, calcium availability and thin-filament calcium sensitivity control whether contraction occurs, with troponin and tropomyosin acting as the switch. Chronically, transcription factors such as GATA4 and MEF2C shape the expression of contractile genes, and they are used in direct reprogramming of fibroblasts into functional cardiomyocytes. Mechanical load and stretch regulate contraction through mechano-electric and mechano-chemo-transduction, which can alter ion channel behavior and signaling. Nucleus mechanosensing adds a layer in which contractile forces influence gene expression. Optogenetic control of cardiac muscle has also been used to stimulate contraction with light, showing that the process can be driven by engineered inputs.
cardiac muscle cell contraction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNNT2 | Cardiomyopathy and altered calcium regulation | Point-mutation knock-in in hiPSC-derived cardiomyocytes |
| TNNI3 | Thin-filament dysfunction | Knockout and rescue in cardiac muscle cells |
| TNNC1 | Calcium-sensing defect in contraction | Point mutation at calcium-binding residues |
| MYH7 | Sarcomeric motor dysfunction | Knock-in of patient variant and contraction assay |
| RYR2 | Calcium release abnormality | Knockout or point mutation with calcium imaging |
Cardiomyopathy and sarcomeric mutations
Mutations in sarcomeric and thin-filament genes, including troponin genes, can alter calcium regulation and contractile performance, contributing to cardiomyopathy phenotypes. Because GO:0086003 describes the actin filament-based contraction process, variants in genes annotated to this term are prioritized in cardiac genetic testing and functional studies. Human cell models are increasingly used to test whether a variant changes contraction.
Arrhythmia and mechano-electric feedback
Contraction is coupled to electrical activity through mechano-electric transduction, so changes in contractile mechanics can influence arrhythmia susceptibility. This link means that genes affecting contraction may also affect rhythm, and vice versa. Studying GO:0086003 therefore helps interpret arrhythmia mechanisms beyond ion channels alone.
Heart failure and calcium handling
Impaired calcium removal or reduced calcium sensitivity can weaken contraction and contribute to heart failure. Because relaxation is part of the same cycle, defects in calcium reuptake can also impair filling. Assays that measure contraction in single cells or engineered tissues are used to dissect these defects.
From cardiac muscle cell contraction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a gene required for contraction? | CRISPR knockout in hiPSC-derived cardiomyocytes |
| Does a patient variant alter contraction? | Point-mutation knock-in in cardiac muscle cells |
| Can a normal gene restore contraction? | Knock-in or overexpression rescue |
| Where does a protein localize during contraction? | Tagged knock-in with live imaging |
| Does overexpression change contractile force? | Overexpression in engineered cardiac tissue |
| Can contraction be controlled externally? | Optogenetic stimulation model |
How to Study the cardiac muscle cell contraction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Microfluidic single-cell assay | Cell shortening and force | Contractile phenotyping |
| hiPSC cardiac muscle ring | Tissue-level beating and force | Human model of contraction |
| Calcium imaging | Cytoplasmic calcium transients | Excitation-contraction coupling |
| Electrophysiology | Action potentials and ion currents | Electrical control of contraction |
| Optogenetics | Light-triggered contraction | Precise temporal control |
| Nucleus mechanosensing assay | Force-dependent nuclear signaling | Mechanotransduction |
| CRISPR editing followed by contraction assay | Causal gene function | Variant validation |
Single-cell contraction assays
Single cardiac muscle cells can be studied in microfluidic chips to measure shortening and force under controlled conditions. These assays are useful for linking molecular perturbations to contractile output. They can be combined with calcium imaging to separate calcium handling from sarcomeric function.
Engineered cardiac tissues and hiPSC models
Human induced pluripotent stem cell-derived cardiac muscle rings provide a biohybrid self-beating actuator that can be used to measure contraction in a tissue context. Such models allow human genetics to be tested directly. They are also suitable for drug testing and gene editing validation.
Calcium and electrophysiology
Calcium imaging and electrophysiology measure the signals that trigger and terminate contraction. These methods help distinguish defects in excitation-contraction coupling from defects in the sarcomere itself. Mechano-electric feedback can also be probed by combining mechanical and electrical measurements.
Optogenetic and mechanosensing readouts
Optogenetic stimulation can drive cardiac muscle contraction with light, providing precise temporal control. Nucleus mechanosensing assays can reveal how contraction-derived forces change nuclear signaling. Together these approaches connect contraction to upstream control and downstream gene expression.
How CRISPR Can Be Used to Study GO:0086003 cardiac muscle cell contraction
Knockout
CRISPR knockout of a candidate gene in cardiomyocytes or hiPSC-derived cardiac cells can test whether the gene is required for cardiac muscle cell contraction. Loss-of-function models are especially useful for sarcomeric and calcium-handling genes. Contractile readouts such as single-cell shortening or tissue beating then reveal the phenotype.
Point Mutation
Point-mutation knock-in allows researchers to introduce a specific patient variant and ask whether it alters contraction. This is important for troponin and other thin-filament genes where single amino acid changes can change calcium sensitivity. Isogenic controls make the comparison rigorous.
Knock-in
Knock-in can be used to add tags, reporters, or rescue cassettes at endogenous loci to study contraction in real time. Tagged sarcomeric proteins can be imaged during contraction to determine localization and dynamics. Knock-in rescue can also test whether a normal sequence restores contraction.
Overexpression
Overexpression of a contractile or regulatory gene can test whether increased dosage changes contraction. This is useful for gain-of-function hypotheses and for engineering stronger or more stable cardiac tissues. Overexpression should be interpreted alongside knockout data to establish causality.
How EDITGENE Supports cardiac muscle cell contraction Research
Researchers studying cardiac muscle cell contraction-related genes often need to determine whether a candidate gene is causally involved in the actin filament-based shortening of cardiomyocytes, rather than merely correlated with it. This requires precise genetic models in relevant cardiac cells, combined with quantitative contractile readouts.
Contact EDITGENE today to design your custom CRISPR model for cardiac muscle cell contraction research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PIK3CA Knockout Hep-G2 Cell Line | EDJ-KQ40 | Human | 5290 | Details Get a Quote |
| CAMK2D Knockout HEK293 Cell Line | EDJ-KQ111 | Human | 817 | Details Get a Quote |
| PIK3CA Knockout HEK293 Cell Line | EDJ-KQ518 | Human | 5290 | Details Get a Quote |
| SLC9A1 Knockout HEK293 Cell Line | EDJ-KQ1430 | Human | 6548 | Details Get a Quote |
| TNNC1 Knockout HEK293 Cell Line | EDJ-KQ1632 | Human | 7134 | Details Get a Quote |
| KCNQ1 Knockout HEK293 Cell Line | EDJ-KQ2359 | Human | 3784 | Details Get a Quote |
| GSN Knockout HEK293 Cell Line | EDJ-KQ4802 | Human | 2934 | Details Get a Quote |
| KCNE1 Knockout HEK293 Cell Line | EDJ-KQ5024 | Human | 3753 | Details Get a Quote |
| TNNC1 Knockout A-549 Cell Line | EDJ-KQ19998 | Human | 7134 | Details Get a Quote |
| SLC9A1 Knockout A-549 Cell Line | EDJ-KQ20975 | Human | 6548 | Details Get a Quote |
| SLC9A1 Knockout HCT 116 Cell Line | EDJ-KQ20976 | Human | 6548 | Details Get a Quote |
| SLC9A1 Knockout HeLa Cell Line | EDJ-KQ20977 | Human | 6548 | Details Get a Quote |
| PIK3CA Knockout HeLa Cell Line | EDJ-KQ18331 | Human | 5290 | Details Get a Quote |
| CAMK2D Knockout A-549 Cell Line | EDJ-KQ18388 | Human | 817 | Details Get a Quote |
| CAMK2D Knockout HCT 116 Cell Line | EDJ-KQ18390 | Human | 817 | Details Get a Quote |
Displaying Records 1 To 15 Of 43 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About cardiac muscle cell contraction
What is GO:0086003 cardiac muscle cell contraction?
GO:0086003 is the Gene Ontology biological process describing the actin filament-based process in which cytoplasmic actin filaments slide past one another, resulting in contraction of a cardiac muscle cell.
What genes are involved in cardiac muscle cell contraction?
Key genes include MYH7, MYH6, ACTC1, TNNT2, TNNI3, TNNC1, TPM1, MYL2, MYL3, TTN, MYBPC3, ATP2A2, RYR2, and CACNA1C, all of which contribute to sarcomere function or calcium handling.
How does calcium trigger cardiac muscle cell contraction?
Calcium binds troponin C, which moves tropomyosin and exposes actin sites so myosin can cycle and slide the filaments.
How is cardiac muscle cell contraction different from skeletal muscle contraction?
The fundamental actin-myosin mechanism is shared, but cardiac cells use cardiac-specific isoforms and regulatory tuning, and the GO term is restricted to cardiac muscle cells.
What diseases are linked to defects in cardiac muscle cell contraction?
Cardiomyopathy, heart failure, and arrhythmia can result from defects in sarcomeric or calcium-handling genes that affect contraction.
How do researchers measure cardiac muscle cell contraction?
Methods include single-cell microfluidic assays, hiPSC-derived cardiac muscle rings, calcium imaging, electrophysiology, and optogenetic stimulation.
Can CRISPR be used to study cardiac muscle cell contraction?
Yes, CRISPR knockout, point-mutation knock-in, knock-in, and overexpression models are used to test causal gene function in contraction.
What are mechano-electric and mechano-chemo-transduction in cardiomyocytes?
They are processes by which mechanical forces from contraction are converted into electrical and chemical signals that regulate the cell.
Why is nucleus mechanosensing important for cardiac muscle cell contraction?
It links contraction-derived forces to changes in nuclear signaling and gene expression, connecting mechanics to long-term cell regulation.
How can human cells be used to study cardiac muscle cell contraction?
Human induced pluripotent stem cell-derived cardiac muscle and direct reprogramming of fibroblasts into cardiomyocytes provide human cell models for contraction studies.
Conclusion
GO:0086003 cardiac muscle cell contraction is a precise Gene Ontology term for the actin filament-based shortening of cardiomyocytes, and it anchors a large body of research on sarcomere biology, calcium signaling, and mechanotransduction. Because contraction is the defining output of the heart, genes annotated to this term are directly relevant to cardiomyopathy, heart failure, and arrhythmia research. Modern models, including hiPSC-derived cardiac tissues and CRISPR-edited cells, now allow researchers to test causality and to screen for new regulators of contraction. Researchers can use EDITGENE services to build the knockout, point-mutation, knock-in, overexpression, and library-screening models needed to study this process rigorously.
References
- 1. Sweeney HL et al.. 2018. Muscle Contraction.. Cold Spring Harb Perspect Biol 10(2) PMID: 29419405
- 2. Morita T et al.. 2024. Human induced pluripotent stem cell-derived cardiac muscle rings for biohybrid self-beating actuator.. Lab Chip 24(14):3377-3387 PMID: 38916038
- 3. Ieda M et al.. 2010. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.. Cell 142(3):375-86 PMID: 20691899
- 4. Li XJ et al.. 2006. Contraction study of a single cardiac muscle cell in a microfluidic chip.. Methods Mol Biol 321:199-225 PMID: 16508074
- 5. Aborode AT et al.. 2024. Troponin C gene mutations on cardiac muscle cell and skeletal Regulation: A comprehensive review.. Gene 927:148651 PMID: 38871035
- 6. Izu LT et al.. 2020. Mechano-electric and mechano-chemo-transduction in cardiomyocytes.. J Physiol 598(7):1285-1305 PMID: 31789427
- 7. Coscarella IL et al.. 2023. Nucleus Mechanosensing in Cardiomyocytes.. Int J Mol Sci 24(17) PMID: 37686151
- 8. Jia Z et al.. 2011. Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery.. Circ Arrhythm Electrophysiol 4(5):753-60 PMID: 21828312
